Mirum Pharmaceuticals CMO Sells Shares to Cover Tax From PRSU Vesting as Trials Advance
Mirum Pharmaceuticals Chief Medical Officer Joanne Quan sold 7,287 shares on March 16, 2026 to satisfy tax-withholding obligations tied to the vesting of performance restricted stock units (PRSUs). Quan had exercised 13,334 PRSUs the previous day. The company has reported several Phase 3 enrollment completions and reiterated sales guidance for fisc…